Pediatric Oncology Febrile neutropenia Invasive fungal disease Pediatric Oncology Febrile neutropenia Invasive fungal disease
Conditions
Interventions
Invasive Fungal Disease in Pediatric Oncology Patients with Febrile Neutropenia
Supportive Care
Febrile neutropenia oncology patient who had invasive fungal disease
Sponsors
Office of Research and Development, Phramongkutklao Hospital and College of Medicine
Eligibility
Sex/Gender
All
Age
0 Years to 21 Years
Inclusion criteria
Inclusion criteria: Pediatric oncology patients with febrile neutropenia who were treated at pediatric department, Phramongkutklao Hospital
Exclusion criteria
Exclusion criteria: Pediatric oncology patients who had not met criteria of febrile neutropenia (fever without neutropenia) Pediatric oncology patients with febrile neutropenia who had been diagnosed with invasive fungal infection before enrolling to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi-squared test with p-value < 0.05 | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factors of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi-squared test with p-value < 0.05 ,Clinical characteristics of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi-squared test with p-value < 0.05 ,Laboratory and imaging of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi-squared test with p-value < 0.05 | — |
Countries
Thailand
Contacts
Public ContactChalinee Monsereenusorn
Phramongkutklao Hospital and College of Medicine
Outcome results
None listed